Dr. Nicholas Osborne has joined the leadership ranks of BMC2 as the new Director of BMC2 Vascular Surgery. Dr. Osborne’s directorship follows 10 years of leadership by Dr. Peter Henke. Dr. Henke will continue his involvement in BMC2 in an ex officio capacity, including as a member of the Vascular Surgery Publication Committee.
Dr. Hitinder Gurm, Program Director of BMC2, said, “Dr. Osborne has been an active and engaged member of BMC2 and we look forward to continuing our mission of improving quality of care and outcomes under his care.”
Implementing a heavier quality improvement focus and ensuring that focus drives decision-making across the consortium is a priority for Dr. Osborne as he looks to the future of BMC2 Vascular Surgery.
BMC2 is well established and delivers a highly valued quality improvement tool to our vascular surgery community. “As we move forward, we aim to foster even more engagement with stakeholders, adding an Advisory Board broadly from our membership to guide the future development of BMC2 long term,” Dr. Osborne explained.
BMC2 members will not only help to drive quality improvement initiatives statewide, but also will have an increased role in determining meeting content. There will be more intention in choosing the focus and theme of meetings to promote gatherings that emphasize quality improvement. More time for discussion and networking will be added to meeting agendas. Dr. Osborne will also prioritize excellent customer service, both to BMC2 members and to sponsor, Blue Cross Blue Shield of Michigan.
An Associate Professor of Surgery and Associate Program Director for the Michigan Medicine Vascular Surgery residency and fellowship training programs, Dr. Osborne practices at both the Frankel Cardiovascular Center and the Ann Arbor Veteran's Affairs Hospital. He is the Chief of Vascular Surgery and Chief of Surgery at the LTC Charles S. Kettles VA Medical Center, Ann Arbor.
Dr. Osborne’s clinical interests include peripheral artery disease, cerebrovascular disease, complex endovascular surgery, and aortic disease. He is a member of the Institute for Healthcare Policy and Innovation. Dr. Osborne has expertise in complex statistical methods and using large databases to examine variations in the care and the quality of care in the United States. He has received both an American Heart Association Career Development Award and an NIH K08 award. His primary focus has been to examine physician and patient decision-making and determine the real-world long-term outcomes of medical, endovascular, and surgical treatment of Peripheral Artery Disease.
High-profile journals including the New England Journal of Medicine, JAMA, Journal of the American Heart Association, Journal of Vascular Surgery, and Medical Care, have published Dr. Osborne’s work. He is also a regular contributor to the Behind the Knife podcast series. Nationally, he is a member of the Appropriateness Committee of the Society for Vascular Surgery and the Executive Council for the Vascular Quality Initiative.
The future is bright, as Dr. Osborne will work to elevate BMC2’s commitment to improving quality of care and outcomes for cardiovascular patients across Michigan and increase the value of participation in BMC2 by fostering member engagement.